GLP-1 without insurance: real options and costs in 2026

If your plan will not pay for a GLP-1, you are not stuck. There are three realistic cash routes in 2026: buying directly from the manufacturer, using a savings offer, or working with a telehealth clinic that prescribes compounded tirzepatide or compounded semaglutide. This guide lays out what each one is, what the published prices are, and how to compare them honestly.

Why insurance rarely covers weight loss GLP-1s

Coverage for weight loss medication is decided plan by plan and employer by employer. Some plans exclude the category entirely. Some cover it only after prior authorization, documentation of other attempts, or a specific diagnosis. Others cover the same molecule for diabetes but not for weight management. None of that is visible from the outside, which is why generic answers on the internet do not help you.

Before you commit to paying cash, spend ten minutes on the phone with the member services number on your insurance card and ask three things: is weight management medication a covered benefit on my specific plan, what prior authorization is required, and what would my copay be if it were approved. Write down the answers. If the answer is no, the rest of this article is your map.

One useful signal: both Eli Lilly and Novo Nordisk now publish self-pay prices on their own pharmacy pages, which means paying out of pocket is a normal, supported path rather than a workaround.

Option 1: manufacturer direct programs

Manufacturer direct means you buy the brand product from a pharmacy channel run or supported by the company that makes it, at a published cash price, without involving your insurance.

LillyDirect self-pay vials

As of 2026-09-16, the LillyDirect Zepbound page lists single-dose vial self-pay prices by strength. The page shows a self-pay price of "Starting at $299/month" for the 2.5 mg/0.5 mL starting dosage, "Starting at $399/month" for 5 mg/0.5 mL, and "Starting at $449/month" for 7.5 mg/0.5 mL "when you refill within 45 days." For each of those, the page states "Terms and conditions apply" and "Needle and syringe purchase required."

Two practical notes. The price is tied to the strength, so the number can move as your provider adjusts your plan of care. And the refill timing condition attached to the higher strength means the lowest listed number is not automatic.

NovoCare self-pay and savings

As of 2026-09-16, the NovoCare Wegovy page states: "Patients new to the Wegovy Savings offer or NovoCare Pharmacy pay $199 for each month of 0.25 mg & 0.5 mg. Offer for 2 monthly fills through December 31, 2026, then $349 per month for Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg and $399 per month for Wegovy HD 7.2 mg." The same page states that eligibility and restrictions apply, that one month is defined as 1 box of 4 pens, and that "Novo Nordisk reserves the right to modify or cancel this program at any time."

Read that structure carefully, because it is the single most common budgeting mistake people make. The $199 number applies to 2 monthly fills for patients new to the offer. After that, the published price steps up.

Option 2: compounded GLP-1 through telehealth

The third route is a licensed telehealth clinic that connects you with a provider who can prescribe compounded tirzepatide or compounded semaglutide, dispensed by a licensed compounding pharmacy. Compounded medications are not FDA approved finished products. A licensed provider determines eligibility.

Here is what compounding actually is, in the words of the regulator. The FDA describes compounding as "generally a practice in which a licensed pharmacist, a licensed physician" combines, mixes or alters ingredients of a drug "to create a medication tailored to the needs of an individual patient." The same page states that "Compounded drugs are not FDA approved, which means the agency does not review their safety, effectiveness or quality before they are marketed" and that although compounded drugs "can serve an important medical need for certain patients, they also may pose risks to patients."

Compounded medications are custom-prepared by licensed compounding pharmacies and are not evaluated by the U.S. Food and Drug Administration for safety or effectiveness. That is the honest frame. It is a different regulatory category from a brand product, and you should decide with a licensed provider whether it is appropriate for you.

If you want the product details, Belle publishes them for compounded tirzepatide and compounded semaglutide. If you want to understand the mechanics of an online visit before you start, how peptide telehealth works walks through the sequence from intake to delivery.

Option 3: savings cards and coupons

Savings offers are manufacturer-funded discounts applied at the pharmacy counter. The clearest published example in this space is the Wegovy Savings offer described above, where the NovoCare page lists $199 for each month of the two lowest strengths for patients new to the offer, for 2 monthly fills through December 31, 2026, then $349 per month or $399 per month depending on the product, as of 2026-09-16.

Three things to check on any savings offer before you build a budget around it:

• How many fills the intro price covers. An offer priced for 2 monthly fills is not an annual price.
• Whether eligibility is restricted. The NovoCare page states that eligibility and restrictions apply.
• Whether the program can change. The NovoCare page states that Novo Nordisk reserves the right to modify or cancel the program at any time.

This same pattern shows up in telehealth. Programs that advertise a very low first month and reset to a higher rate afterward are common. Neither approach is dishonest, but the only fair comparison is total cost over six or twelve months, including anything you have to buy separately. On the LillyDirect page, for example, the self-pay vial listings state that needle and syringe purchase is required.

What Belle costs

Belle publishes live pricing rather than a number in an article that goes stale. The table below shows current pricing for the weight loss programs, including compounded tirzepatide and compounded semaglutide.

If you want the cost breakdown in more depth, including what changes over time and what is bundled, read compounded tirzepatide cost in 2026 and compounded semaglutide cost in 2026. If you are trying to understand how a compounded product differs from a brand product, compounded semaglutide vs Wegovy and Ozempic covers that directly.

Food support matters as much as the prescription for most people, and Belle includes nutrition guidance as part of the weight loss program rather than as a separate upsell.

How to decide

Work through this in order. It takes about an afternoon and it saves people from paying twice.

1. Confirm the coverage answer in writing. Call your plan, ask whether weight management medication is covered, and ask what prior authorization would require. If it is covered, that is almost always the cheapest path.
2. Price the manufacturer route for the specific product your provider is considering. Use the published self-pay pages rather than third party summaries, because the numbers and the conditions change.
3. Check whether you qualify for a savings offer, and note how many fills the intro price covers and what the price becomes after that.
4. Price the compounded telehealth route on total monthly cost, and read the safety information so you understand that compounded medications are not FDA approved finished products.
5. Multiply your best option by twelve. A program that looks cheaper in month one is often not cheaper in month seven.
6. Bring all of it to a licensed provider. Cost is one input. Your medical history, other medications and goals decide what is actually appropriate for you.

Belle providers review your intake, ask follow up questions where something needs clarifying, and decline treatment when it is not appropriate. You can see who is behind that on the clinical team page, and browse everything else Belle offers under treatments. More cost and comparison guides live on the Learn hub.

Nothing here is medical advice. Decisions about starting, continuing or stopping a GLP-1 belong with a licensed provider who knows your history.